124I-NaI PET/CT based 3-D radiobiological Dosimetry (3D-RD) for 131I-NaI therapy of metastatic well-differentiated thyroid cancer.
Institution: MedStar Washington Hospital CenterDepartment: Medicine/Nuclear MedicineForm of publication: ConferenceYear: 2013Conference information: Abstract presented at: Society of Nuclear Medicine Annual Meeting 2013., Vancouver, British Columbia., 2013/06/08/ | Fiscal year: FY201332Local accession number: 2013_2Date added to catalog: 2014-04-14Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Conference | MedStar Authors Catalog | Conference | Available |